Wall Street Analysts Think Design Therapeutics (DSGN) Could Surge 39.72%: Read This Before Placing a Bet
Design Therapeutics(DSGN) ZACKS·2024-08-21 22:55
Shares of Design Therapeutics, Inc. (DSGN) have gained 23.7% over the past four weeks to close the last trading session at 7 indicates a potential upside of 39.7%.The average comprises three short-term price targets ranging from a low of 12, with a standard deviation of $4.36. While the lowest estimate indi ...